Afya (AFYA) Investor presentation summary
Event summary combining transcript, slides, and related documents.
Investor presentation summary
8 May, 2026Mission and purpose
Aims to provide an integrated ecosystem for education and medical practice solutions throughout the medical journey, enhancing professional development and productivity.
Seeks to transform health in partnership with those dedicated to medicine as a vocation.
Market position and business segments
Recognized as the largest hub for medical education and practice solutions in Brazil, with a 9% market share and 3,768 approved private medical seats.
Operates across undergraduate programs, continuing education, and medical practice solutions, serving every stage of a physician's career.
Offers proprietary teaching methodologies, AI-enhanced tools, and nationwide partnerships for clinical training.
Operational highlights
Medical course net ticket increased by 4.6%, outpacing inflation.
Total student base reached a record 57,000, with strong B2B revenue growth of 17%.
Operating medical seats rose to 3,768, with 26,494 undergraduate students and 56,531 continuing education students.
Monthly active users for medical practice solutions totaled 220,528.
Latest events from Afya
- Revenue up 8.2% YoY, adjusted EBITDA up 4.0%, and net income up 1.8%.AFYA
Q1 202611 May 2026 - Double-digit growth in revenue, profit, and cash flow, with strong 2026 outlook and capital discipline.AFYA
Q4 202513 Mar 2026 - Double-digit growth, margin gains, and raised 2024 guidance driven by organic and acquisition-led expansion.AFYA
Q2 20242 Feb 2026 - Growth in medical education and digital health is driven by innovation, cash flow, and sector leadership.AFYA
Investor Day 202418 Jan 2026 - Net revenue and EBITDA rose over 16% and 25% YoY, with strong cash flow and margin gains.AFYA
Q3 202414 Jan 2026 - Integrated education, technology, and clinical practice drive growth, innovation, and strong 2025 guidance.AFYA
Investor Day 202529 Dec 2025 - Double-digit growth, margin expansion, and strong cash flow with disciplined capital management.AFYA
Q3 202526 Dec 2025 - Net income up 60.1%, margin at 44.1%, and 2025 guidance signals further growth.AFYA
Q4 202425 Dec 2025 - Record EBITDA margin, strong cash flow, and market leadership marked the robust 1Q25 results.AFYA
Q1 202526 Nov 2025